Among 164 gastric MALT lymphoma patients who underwent eradication therapy as primary treatment, 36 were negative for both the API2-MALT1 fusion gene and Hp infection. The gene discussed is BIRC3; the disease is gastric mucosa-associated lymphoid tissue lymphoma.